Organon & Co. (OGN) News Today $10.46 -0.39 (-3.59%) Closing price 03:59 PM EasternExtended Trading$10.52 +0.06 (+0.57%) As of 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OGN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), RespectivelySeptember 19 at 6:00 AM | businesswire.comWedmont Private Capital Acquires 106,561 Shares of Organon & Co. $OGNSeptember 19 at 4:39 AM | marketbeat.comGilman Hill Asset Management LLC Has $1.97 Million Stock Holdings in Organon & Co. $OGNSeptember 18 at 6:55 AM | marketbeat.comTriumph Capital Management Grows Stock Position in Organon & Co. $OGNSeptember 17 at 6:39 AM | marketbeat.comOrganon & Co. (OGN) Wins FDA Nod for Biosimilars to Prolia and XgevaSeptember 16 at 5:50 PM | insidermonkey.comOrganon & Co. $OGN Shares Purchased by Douglas Lane & Associates LLCSeptember 16 at 4:29 AM | marketbeat.comCacti Asset Management LLC Makes New Investment in Organon & Co. $OGNSeptember 15, 2025 | marketbeat.comBelpointe Asset Management LLC Invests $531,000 in Organon & Co. $OGNSeptember 15, 2025 | marketbeat.comWBI Investments LLC Invests $946,000 in Organon & Co. $OGNSeptember 13, 2025 | marketbeat.comAmundi Has $10.39 Million Stock Holdings in Organon & Co. $OGNSeptember 12, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Increases Holdings in Organon & Co. $OGNSeptember 11, 2025 | marketbeat.comAQR Capital Management LLC Lowers Stock Position in Organon & Co. $OGNSeptember 10, 2025 | marketbeat.comKuehn Law Encourages Investors of Organon & Co. to Contact Law FirmSeptember 9, 2025 | prnewswire.comRaymond James Financial Inc. Grows Stock Holdings in Organon & Co. $OGNSeptember 8, 2025 | marketbeat.comNew Vernon Capital Holdings II LLC Purchases 230,650 Shares of Organon & Co. $OGNSeptember 7, 2025 | marketbeat.comOrganon & Co. $OGN Shares Acquired by Gotham Asset Management LLCSeptember 7, 2025 | marketbeat.comBanque Transatlantique SA Raises Stock Position in Organon & Co. $OGNSeptember 6, 2025 | marketbeat.comADAR1 Capital Management LLC Cuts Stock Position in Organon & Co. $OGNSeptember 5, 2025 | marketbeat.comCaption Management LLC Sells 28,131 Shares of Organon & Co. $OGNSeptember 4, 2025 | marketbeat.comUS Food and Drug Administration (FDA) Approves Henlius and Organon's BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), RespectivelySeptember 2, 2025 | businesswire.comNorthern Trust Corp Grows Position in Organon & Co. $OGNSeptember 2, 2025 | marketbeat.comOrganon & Co. (OGN) Advances VTAMA Cream, Strengthens Women’s Health PortfolioAugust 29, 2025 | finance.yahoo.comDeutsche Bank AG Has $1.06 Million Holdings in Organon & Co. $OGNAugust 27, 2025 | marketbeat.comQuantbot Technologies LP Takes Position in Organon & Co. $OGNAugust 26, 2025 | marketbeat.com589,186 Shares in Organon & Co. $OGN Acquired by Nuveen LLCAugust 26, 2025 | marketbeat.comAlgert Global LLC Acquires New Stake in Organon & Co. $OGNAugust 23, 2025 | marketbeat.comInvesco Ltd. Has $28.85 Million Position in Organon & Co. $OGNAugust 22, 2025 | marketbeat.comOrganon & Co. (NYSE:OGN) Shares Sold by Brandywine Global Investment Management LLCAugust 18, 2025 | marketbeat.comRussell Investments Group Ltd. Sells 128,059 Shares of Organon & Co. (NYSE:OGN)August 18, 2025 | marketbeat.comVanguard Group Inc. Sells 699,976 Shares of Organon & Co. (NYSE:OGN)August 17, 2025 | marketbeat.comOrganon & Co. (NYSE:OGN) Shares Purchased by KLCM Advisors Inc.August 16, 2025 | marketbeat.comThere May Be Some Bright Spots In Organon's (NYSE:OGN) EarningsAugust 15, 2025 | finance.yahoo.comLPL Financial LLC Has $4.87 Million Holdings in Organon & Co. (NYSE:OGN)August 15, 2025 | marketbeat.comPublic Sector Pension Investment Board Has $12.16 Million Position in Organon & Co. (NYSE:OGN)August 14, 2025 | marketbeat.comNYSE: OGN Lawsuit Alert: Investors who lost money with Organon & Co. (NYSE: OGN) shares should contact the Shareholders FoundationAugust 13, 2025 | prnewswire.comOrganon: Valuation Discount Offset By Structural HeadwindsAugust 12, 2025 | seekingalpha.comRead This Before Considering Organon & Co. (NYSE:OGN) For Its Upcoming US$0.02 DividendAugust 11, 2025 | finance.yahoo.comOrganon & Co. (NYSE:OGN) Given Average Recommendation of "Moderate Buy" by BrokeragesAugust 8, 2025 | marketbeat.comOrganon & Co. to Issue Quarterly Dividend of $0.02 (NYSE:OGN)August 7, 2025 | marketbeat.comOrganon & Co. (OGN) Reports Q2 2025 ResultsAugust 7, 2025 | insidermonkey.comOrganon & Co. Earnings Call: Resilience Amid ChallengesAugust 7, 2025 | theglobeandmail.comOrganon & Co. (NYSE:OGN) Second-Quarter Results: Here's What Analysts Are Forecasting For This YearAugust 7, 2025 | finance.yahoo.comOrganon Q2 Earnings: It May Be Time To Desert This Sinking Ship (Downgrade)August 6, 2025 | seekingalpha.comOrganon & Co. (OGN) Slashes 13.13% on Disappointing EarningsAugust 6, 2025 | msn.comOrganon & Co. (NYSE:OGN) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPSAugust 6, 2025 | marketbeat.comOrganon & Co. (NYSE:OGN) Trading Down 9.4% - Here's WhyAugust 6, 2025 | marketbeat.comOrganon (OGN) Fiscal Q2 Revenue Beats 1%August 6, 2025 | fool.comOrganon & Co. Reports Q2 2025 Financial ResultsAugust 6, 2025 | tipranks.comOrganon & Co. (OGN) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comOrganon & Co. 2025 Q2 - Results - Earnings Call PresentationAugust 5, 2025 | seekingalpha.com Get Organon & Co. News Delivered to You Automatically Sign up to receive the latest news and ratings for OGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OGN Media Mentions By Week OGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OGN News Sentiment▼1.470.79▲Average Medical News Sentiment OGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OGN Articles This Week▼925▲OGN Articles Average Week Get the Latest News and Ratings for OGN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Organon & Co. and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies QGEN News BBIO News ROIV News MRNA News ELAN News VRNA News RVMD News GRFS News ABVX News RYTM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:OGN) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organon & Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organon & Co. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
